Virax Biolabs Group Ltd - SHS NEW (VRAX)

Historical Portfolio Holders from Q4 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SHS NEW
Shares, excl. options Q3 2024
218K
Holdings value Q3 2024
$424K
Value change Q3 2024
+$329K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
5
Number of buys Q3 2024
5
Number of sells Q3 2024
-4
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 218K $424K +$329K $1.94 5
2024 Q2 70.8K $81.8K +$68.1K $1.16 7
2024 Q1 17.5K $12.5K -$182K $0.72 3
2023 Q4 134K $195K +$195K $1.46 4